| SpectraBase Spectrum ID |
2oyRIHMi9nU |
| Name |
3-Me-4-MA N-(4-ethylbenzoyl) |
| Classification |
Amphetamine analog designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
311.188529047 u |
| Formula |
C20H25NO2 |
| InChI |
InChI=1S/C20H25NO2/c1-5-16-6-9-18(10-7-16)20(22)21-15(3)13-17-8-11-19(23-4)14(2)12-17/h6-12,15H,5,13H2,1-4H3,(H,21,22) |
| InChIKey |
UVAGUFFYIBJNPW-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
311.425 g/mol |
| Nominal Mass |
311 u |
| Quality |
971 |
| Retention Index |
2612 |
| SMILES |
C(C=1C=CC(=CC1)CC)(NC(CC1=CC(=C(C=C1)OC)C)C)=O |
| SPLASH |
splash10-03e9-1900000000-0c1bc5e29d1e2ae91998 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
4-Ethyl-N-[1-(4-methoxy-3-methylphenyl)propan-2-yl]benzamide |
| Technique |
GC/MS |
| Wiley ID |
DD2024_023932 |
